The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage IC ovarian carcinoma


Topuz E., Eralp Y., Saip P., Aydiner A., Tas F. , Salihoglu Y. , ...More

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, vol.22, no.1, pp.70-73, 2001 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 1
  • Publication Date: 2001
  • Title of Journal : EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
  • Page Numbers: pp.70-73

Abstract

Objective: Patients With stage I ovarian cancer show a high incidence of recurrent disease ranging from 30% to 50% which may be associated with ii shortened survival. Therefore. a subset of early-stage patients with poor prognostic factors who are most likely to present with recurrent disease in the next few years may benefit from adjuvant treatment.